DERM Journey Medical Corporation
Healthcare$6.12+2.68%ClosedMarket Cap: $168.4M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
5.28
P/S
2.54
EV/EBITDA
-90.05
DCF Value
$-7.65
FCF Yield
-4.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
60.4%
Operating Margin
-9.8%
Net Margin
-14.8%
ROE
-35.6%
ROA
-10.5%
ROIC
-11.3%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $16.0M | 54.0% | $-1.5M | $-2.2M | $— | — |
| Q4 null | $16.1M | 59.5% | $-443.0K | $-1.2M | $— | — |
| FY null | $61.9M | 59.3% | $-8.2M | $-11.4M | $— | — |
| Q3 null | $17.6M | 67.4% | $-1.5M | $-2.3M | $— | — |
| Q2 null | $15.0M | 60.0% | $-2.9M | $-3.8M | $— | — |
| Q1 null | $13.1M | 55.4% | $-3.3M | $-4.1M | $— | — |
| Q4 null | $13.6M | 83.6% | $2.2M | $1.5M | $— | — |
| FY null | $56.1M | 62.8% | $-13.7M | $-14.7M | $— | — |
| Q3 null | $14.6M | 63.9% | $-2.9M | $-2.4M | $— | — |
| Q2 null | $14.9M | 56.0% | $-2.9M | $-3.4M | $— | — |
| Q1 null | $13.0M | 47.7% | $-10.1M | $-10.4M | $— | — |
| Q4 2023 | $15.3M | 60.6% | $-2.1M | $-2.1M | $-0.11 | — |